April 25, 2018

Hot Stock to Watch: Nektar Therapeutics (NKTR)

13 November 2017, 07:16 | Silvia Roy

Hot Stock to Watch: Nektar Therapeutics (NKTR)

Nektar Therapeutics

Finally, Riverhead Capital Management LLC increased its stake in shares of Nektar Therapeutics by 78.7% in the second quarter.

Several other hedge funds have also recently modified their holdings of NKTR. The Nektar Therapeutics has Relative Strength Index (RSI 14) of 84.59 along with Average True Range (ATR 14) of 1.44. Over the last quarter, insiders have sold 1,024,757 shares of company stock valued at $25,974,361. State Street Corp raised its stake in shares of Nektar Therapeutics by 11.3% in the second quarter. The company's price to sales ratio for trailing twelve months is 13.51 and price to book ratio for most recent quarter is 2.27, whereas price to cash per share for the most recent quarter is 62.20. LS Investment Advisors LLC increased its stake in shares of Nektar Therapeutics by 8.8% in the second quarter. Municipal Employees Retirement System of MI now owns 30,250 shares of the biopharmaceutical company's stock valued at $520,000 after buying an additional 490 shares during the last quarter. Rothschild Asset Management Inc. now owns 1,182,422 shares of the biopharmaceutical company's stock valued at $28,378,000 after purchasing an additional 56,672 shares during the last quarter. Finally, PineBridge Investments L.P. boosted its stake in shares of Nektar Therapeutics by 4.0% in the second quarter. LS Investment Advisors LLC now owns 6,594 shares of the biopharmaceutical company's stock worth $129,000 after buying an additional 535 shares during the period. American International Group Inc. now owns 118,366 shares of the biopharmaceutical company's stock valued at $2,841,000 after purchasing an additional 6,476 shares during the last quarter.

4 dead in crash on I-94, eastbound lanes closed at Allard
Authorities are investigating after four people were killed in a crash on I-94 near Detroit early Monday morning. Police tell WWJ that alcohol may have been a factor, but the investigation is ongoing.

Nektar Therapeutics (NASDAQ:NKTR) was the recipient of some unusual options trading activity on Thursday.

At the time of writing, the stock was trading at $1.87. Nektar Therapeutics has a 12-month low of $10.52 and a 12-month high of $19.98. Investors will be keeping a close eye on the stock during this session to see if the upward trend will remain throughout the day. Breaking that down further, it has performed 36.84% for the week, 41.18% for the month, 68.57% over the last quarter, 64.06% for the past half-year and 137.57% for this a year ago. Nektar Therapeutics had a negative return on equity of 190.68% and a negative net margin of 42.08%. The business had revenue of $36.30 million for the quarter, compared to analysts' expectations of $32.42 million. During the same quarter previous year, the firm earned ($0.06) earnings per share. The business's revenue was down 39.4% on a year-over-year basis. If you are accessing this report on another domain, it was illegally copied and reposted in violation of US and global copyright & trademark legislation. World Asset Management Inc boosted its stake in Nektar Therapeutics by 5.6% in the 2nd quarter. They issued a "buy" rating and a $35.00 target price on the stock. Zacks Investment Research lowered shares of Nektar Therapeutics from a "buy" rating to a "hold" rating in a research report on Friday, August 11th. More interesting news about Nektar Therapeutics (NASDAQ:NKTR) were released by: and their article: "Nektar Therapeutics (NKTR) and Bristol-Myers Squibb (BMY) Report First Data ..." published on November 13, 2017 as well as's news article titled: "New Research Collaboration Between BioXcel Therapeutics and Nektar to Evaluate ..." with publication date: November 13, 2017. If the $41.31 price target is reached, the company will be worth $537.30 million more. BidaskClub upgraded shares of Nektar Therapeutics from a "sell" rating to a "hold" rating in a research report on Thursday, August 17th. Jefferies Group LLC restated a "buy" rating and issued a $23.00 price target on shares of Nektar Therapeutics in a research report on Friday, July 21st. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. The stock was sold at an average price of $19.26, for a total value of $1,766,411.64. Also, SVP Stephen K. Doberstein sold 396,323 shares of Nektar Therapeutics stock in a transaction that occurred on Wednesday, November 8th. Following the transaction, the chief executive officer now directly owns 235,838 shares of the company's stock, valued at $5,558,701.66. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. About 85,312 shares traded or 1.53% up from the average. On Wednesday, November 8 the stock rating was maintained by William Blair with "Buy". The disclosure for this purchase can be found here.

(OXY) Holdings Cut by Candriam Luxembourg SCA
Confluence Investment Management LLC boosted its stake in shares of Occidental Petroleum 7.4% in the second quarter. Peloton Wealth Strategists holds 1.02% of its portfolio in Occidental Petroleum Corporation (NYSE:OXY) for 21,900 shares.

In the market the company is trading up by 18.83% at $38.62 and has one of the biggest price gains of the day.

Nektar Therapeutics is a biopharmaceutical firm that discovers and develops medicines in areas of high unmet medical need.

Garth Brooks announces date of 6th show at Bridgestone Arena
Brooks has now sold over 6.3 million tickets on the tour and tickets are still selling, according to a news release. Garth Brooks is following a sellout of his upcoming Nashville tour stop with another show date in Music City.

Other News

Trending Now

Hot Stock Analysis: General Motors Company (GM)
Finally, Commonwealth Bank of Australia increased its stake in shares of General Motors by 12.5% during the second quarter. The firm now has a $10.00 price objective on the auto manufacturer's stock, up from their prior price objective of $9.00.

Putin and Erdogan to use meeting next week to discuss Syria - agencies
The leaders will exchange views on bilateral relations as well as regional and global developments, particularly Syria . The meeting , which is closed to the media, started at 5.20 p.m local time (1420GMT).

Chelsea hope Dominic Solanke's England call-up will result in Liverpool paying £10million
Chelsea turned down Liverpool's initial £3mil offer instead demanding a transfer fee north of £10m. Liverpool must have been dreading Dominic Solanke's England call-up.

Analysts Are Gushing Over The Procter & Gamble Company (PG), AveXis, Inc. (AVXS)
Insight 2811 Inc increased its stake in Target Corp (TGT) by 105.37% based on its latest 2017Q2 regulatory filing with the SEC. Of the analysts who provided ratings, 7 rated the company a Hold, 1 rated it a Moderate Buy, and 4 rated it a Strong Buy.

Michael Buble to headline BST following son Noah's cancer diagnosis
Michael will take to the stage on Friday 13 July 2018, with tickets on sale for the gig from 9am on Friday 17 November. Michael Buble is to return to the United Kingdom for his first performance since his son was diagnosed with cancer.

Grace seals sweet Nedbank Challenge victory
He continued, "It was great to finish the way I did and bogey-free it was and it was great to be able to pull it off". It's Africa's Major for a reason and what a special place it is.

Ronaldo: I see myself in Man Utd striker Rashford
When you do that, that's when you play your best football. 'It was at Old Trafford and I always remember it. Rashford is nearly certain to score a hat-trick against Real Madrid in the Champions League now.

Hiten Tejwani's 'big sacrifice' for friend Akash in Bigg Boss
Like a true friend, Luv would agree for it and would confidently go around in the house with the word stamped on his head. The twist would be that one person from the house could save them from nomination by making a huge sacrifice.

Yuexiu Real Estate Investment Trust (SEHK:405) Quant Scorecard In Focus
This is calculated by taking weekly log normal returns and standard deviation of the share price over one year annualized. The Westfield Capital Management Company Lp holds 155,124 shares with $13.55 million value, up from 128,060 last quarter.

Trump response to Virginia election showed him 'at his worst'
During Mark Warner's successful 2001 run for governor, a popular local bluegrass band wrote ballads in support of his campaign. But I don't think people should be under any illusions that it means that there's no debate inside the Democratic Party.